ADRA1D
Basic information
Region (hg38): 20:4220630-4249287
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ADRA1D gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 39 | 40 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 39 | 1 | 1 |
Variants in ADRA1D
This is a list of pathogenic ClinVar variants found in the ADRA1D region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-4221535-C-G | not specified | Uncertain significance (May 09, 2023) | ||
20-4221642-C-T | not specified | Uncertain significance (Apr 12, 2024) | ||
20-4221701-A-G | not specified | Uncertain significance (May 27, 2022) | ||
20-4221705-T-C | not specified | Uncertain significance (Sep 28, 2022) | ||
20-4221731-C-T | not specified | Uncertain significance (Jun 02, 2024) | ||
20-4221735-A-G | not specified | Likely benign (Jul 05, 2023) | ||
20-4221810-G-T | not specified | Uncertain significance (Sep 22, 2022) | ||
20-4221812-G-C | not specified | Uncertain significance (Oct 12, 2021) | ||
20-4221815-C-A | not specified | Uncertain significance (Aug 01, 2022) | ||
20-4221872-G-A | not specified | Uncertain significance (May 09, 2022) | ||
20-4221933-G-T | not specified | Uncertain significance (Mar 21, 2023) | ||
20-4221995-A-C | not specified | Uncertain significance (Mar 18, 2024) | ||
20-4222011-G-C | not specified | Uncertain significance (Dec 16, 2021) | ||
20-4222023-G-T | not specified | Uncertain significance (Mar 24, 2023) | ||
20-4222041-T-C | not specified | Uncertain significance (Jun 01, 2023) | ||
20-4247886-C-G | not specified | Uncertain significance (Apr 09, 2024) | ||
20-4248001-G-C | not specified | Uncertain significance (Sep 20, 2022) | ||
20-4248008-C-T | not specified | Uncertain significance (Apr 20, 2024) | ||
20-4248009-C-A | not specified | Uncertain significance (Apr 23, 2024) | ||
20-4248020-G-T | not specified | Uncertain significance (Jul 13, 2022) | ||
20-4248032-C-G | not specified | Uncertain significance (Jan 19, 2024) | ||
20-4248114-G-C | not specified | Uncertain significance (Oct 03, 2022) | ||
20-4248140-A-G | not specified | Uncertain significance (Aug 03, 2022) | ||
20-4248159-T-C | not specified | Uncertain significance (Apr 01, 2024) | ||
20-4248180-C-T | not specified | Uncertain significance (Jun 30, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ADRA1D | protein_coding | protein_coding | ENST00000379453 | 2 | 28393 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000401 | 0.635 | 125603 | 0 | 27 | 125630 | 0.000107 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.601 | 295 | 326 | 0.906 | 0.0000198 | 3534 |
Missense in Polyphen | 69 | 87.236 | 0.79096 | 960 | ||
Synonymous | 1.32 | 137 | 158 | 0.866 | 0.0000105 | 1287 |
Loss of Function | 0.831 | 8 | 11.0 | 0.729 | 5.45e-7 | 117 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000178 | 0.000178 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000174 | 0.000163 |
Finnish | 0.000415 | 0.000370 |
European (Non-Finnish) | 0.0000571 | 0.0000528 |
Middle Eastern | 0.000174 | 0.000163 |
South Asian | 0.0000734 | 0.0000653 |
Other | 0.000352 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: This alpha-adrenergic receptor mediates its effect through the influx of extracellular calcium.;
- Pathway
- Adrenergic signaling in cardiomyocytes - Homo sapiens (human);Calcium signaling pathway - Homo sapiens (human);Vascular smooth muscle contraction - Homo sapiens (human);Salivary secretion - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);cGMP-PKG signaling pathway - Homo sapiens (human);Antiarrhythmic Pathway, Pharmacodynamics;Sympathetic Nerve Pathway (Neuroeffector Junction);GPCRs, Other;GPCRs, Class A Rhodopsin-like;Calcium Regulation in the Cardiac Cell;Monoamine GPCRs;Signaling by GPCR;Signal Transduction;Adrenoceptors;Amine ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (12/13) signalling events;G alpha (q) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.118
Haploinsufficiency Scores
- pHI
- 0.144
- hipred
- N
- hipred_score
- 0.400
- ghis
- 0.520
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.161
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Adra1d
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); muscle phenotype;
Gene ontology
- Biological process
- DNA metabolic process;G protein-coupled receptor signaling pathway;adenylate cyclase-modulating G protein-coupled receptor signaling pathway;cell-cell signaling;multicellular organism development;cell population proliferation;positive regulation of cell population proliferation;adenylate cyclase-activating adrenergic receptor signaling pathway
- Cellular component
- plasma membrane;integral component of plasma membrane
- Molecular function
- adrenergic receptor activity;alpha1-adrenergic receptor activity;protein binding